BM

Babulal Manordas Soni

Director Director DIN 02665022
DIN 02665022 First appointment May 2009 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since May 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Babulal Manordas Soni

Data last updated:

Babulal Manordas Soni has 17 years in corporate governance. Formerly with 1 company, such as Althea Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02665022
Primary Designation Director
First Appointment 08 May 2009
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Althea Pharma Private Limited U24232GJ2004PTC044200
Director08 May 20092004₹63.27 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Althea Pharma Private Limited
Premium access

Shareholding and investment profile for Babulal Manordas Soni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Babulal Manordas Soni

Babulal Manordas Soni has 17 years in corporate governance. Formerly with 1 company, such as Althea Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Babulal Manordas Soni has expertise in General Business.

Babulal Manordas Soni has 17 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available